NASDAQ: ARCT       Arcturus Therapeutics Ltd
Last Price Today's Change   Day's Range   Trading Volume
46.20   -2.05 (4.25%)  45.66 - 49.71  642,498


Avg Volume (4 weeks):943,021
4 Weeks Range:29.31 - 51.51
4 Weeks Price Volatility (%):
52 Weeks Range:8.49 - 62.97
52 Weeks Price Volatility (%):
Average Price Target: 12.00
Price Target Upside/Downside: -34.20


No recent Headlines for this stock.

Business Background

Alcobra Ltd is a biopharmaceutical company. It is focused on the development and commercialization of novel treatments for central nervous system and cognitive disorders. The company' s product candidates include Abuse-Deterrent Amphetamine Immediate-Release (ADAIR), a proprietary, abuse-deterrent oral formulation of immediate-release (short-acting) dextroamphetamine for the treatment of attention deficit hyperactivity disorder (ADHD) and narcolepsy; and Metadoxine Extended Release (MDX), a proprietary oral drug for the treatment of ADHD and other cognitive disorders, including Fragile X syndrome. Geographically all the operations are operated through the regions of Israel.

  Be the first to like this.

I3 Messenger
Individual or Group chat with anyone on I3investor

2076  3758  237  2993 

Top 10 Active Counters
 GNUS 3.62+1.31 
 NIO 9.305+1.395 
 LK 1.38-1.62 
 SOLO 3.30+0.97 
 WKHS 21.25+2.07 
 AAL 12.549-0.261 
 AVP 5.60-0.05 
 SQQQ 7.06-0.23 
 PCG 9.595+0.565 
 GE 6.845+0.105 
Partners & Brokers